• OPEN AN ACCOUNT
Indian Indices
Sensex
72,638.70 -429.11
( -0.59%)
Global Indices
Nasdaq
51,551.76 262.86
(0.51%)
Dow Jones
7,841.47 46.52
(0.60%)
Hang Seng
70,229.08 -454.90
(-0.64%)
Nikkei 225
10,456.95 -84.74
(-0.80%)
Forex
USD-INR
96.27 0.31
(0.32%)
EUR-INR
107.88 -0.09
(-0.09%)
GBP-INR
127.24 0.23
(0.18%)
JPY-INR
0.61 0.00
(0.27%)

EQUITY - MARKET SCREENER

Sunrest Lifescience Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
91669
INE0PLZ01012
44.9147092
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNREST
5.35
16.52
EPS(TTM)
Face Value()
Div & Yield %
7.2
10
0
 

Shanti Overseas (India) reports consolidated net loss of Rs 9.26 crore in the March 2026 quarter
Jun 01,2026
Net loss of Shanti Overseas (India) reported to Rs 9.26 crore in the quarter ended March 2026 as against net profit of Rs 0.28 crore during the previous quarter ended March 2025. Sales rose 358.50% to Rs 6.74 crore in the quarter ended March 2026 as against Rs 1.47 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 7.50 crore in the year ended March 2026 as against net loss of Rs 2.79 crore during the previous year ended March 2025. Sales declined 41.61% to Rs 13.92 crore in the year ended March 2026 as against Rs 23.84 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales6.741.47 359 13.9223.84 -42
OPM %-46.4412.93 --52.23-18.96 -
PBDT-4.520.28 PL -2.48-3.44 28
PBT-4.500.26 PL -2.48-3.55 30
NP-9.260.28 PL -7.50-2.79 -169